RCUS Insider Trading Activity and SEC Form 4 Filings
Trump's trades in RCUS
From his financial disclosures
-
0 purchases
$16K+
2 sales
Sale
Jul 29, 2026
Reported 55d later
$1K - $15K
Sale
May 15, 2026
Reported 47d later
$15K - $50K
Many orders in these accounts are placed by the account manager.
RCUS insider trading summary
Over the past 12 months, insiders at Arcus Biosciences, Inc. (RCUS) reported 35 sales worth $11.4M by 7 insiders and no open-market purchases on SEC Form 4. Net insider selling was $11.4M.
Latest RCUS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 21, 2026 | Alexander Azoy | Chief Accounting Officer | Sell | $85K (2,827 @ $30.00) |
| Jul 10, 2026 | Juan C. Jaen | President | Sell | $566K (19,799 @ $28.61) |
| Jul 10, 2026 | Juan C. Jaen | President | Sell | $8K (268 @ $29.40) |
| Jul 9, 2026 | Juan C. Jaen | President | Sell | $1.5M (48,502 @ $30.05) |
| Jun 24, 2026 | Juan C. Jaen | President | Sell | $191K (6,431 @ $29.66) |
| Jun 23, 2026 | Juan C. Jaen | President | Sell | $48K (1,697 @ $28.06) |
| Jun 23, 2026 | Juan C. Jaen | President | Sell | $389K (14,067 @ $27.69) |
| Jun 22, 2026 | Juan C. Jaen | President | Sell | $250K (9,236 @ $27.03) |
| May 11, 2026 | Robert C. Goeltz II | Chief Financial Officer | Sell | $199K (7,763 @ $25.63) |
| Jan 5, 2026 | Juan C. Jaen | President | Sell | $633K (29,670 @ $21.34) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.